iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $39K invested in iPath Pure Beta Sugar ETN in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
11% more capital invested
Capital invested by funds: $35K → $39K (+$4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$10.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32 |
Top Sellers
SGAR Hedge Fund Activity: Q3 2014 in Review
2 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q3 2014, worth a combined $39K — up 11% from $35K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SGAR positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS, adding an estimated $10.9K.
- 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q3 2014, up from 1 in Q2 2014.
- Funds reported $39K of iPath Pure Beta Sugar ETN stock for Q3 2014, up 11% quarter-over-quarter.
- 1 fund opened new iPath Pure Beta Sugar ETN positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest iPath Pure Beta Sugar ETN buyer in Q3 2014 was UBS, an estimated $10.9K added.
Based on aggregated 13F filings for Q3 2014.